| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/21/2011 | CN101085015B Traditional Chinese medicinal composition containing red sage root, notoginseng, safflower and dalbergia oil and its preparation |
| 09/21/2011 | CN101085005B Traditional Chinese medicinal composition containing red sage root, ligusticum wallichii and dalbergia oil and its preparation |
| 09/21/2011 | CN101084999B Compound red sage root freezing-dried powder injection containing notoginseng and its preparation method |
| 09/21/2011 | CN101084948B Method for preparing saikosaponin |
| 09/21/2011 | CN101031290B Modafinil modified release pharmaceutical compositions |
| 09/21/2011 | CN101010066B Stabilised prostaglandin composition |
| 09/21/2011 | CN100998781B Traditional Chinese medicine capsule for relieving exterior syndrome, removing dampness regulating the stomach and its preparing method |
| 09/20/2011 | US8022279 Liposomal formulations of anthracycline agents and cytidine analogs |
| 09/20/2011 | US8022266 Method of treating a wound utilizing suction |
| 09/20/2011 | US8022082 Method for the administration of an anticholinergic by inhalation |
| 09/20/2011 | US8022031 Liquid composition of factor VII polypeptides |
| 09/20/2011 | US8021869 Method of cell storage in a delivery system comprising a fibrous matrix |
| 09/20/2011 | US8021834 Use of microparticles combined with submicron oil-in-water emulsions |
| 09/20/2011 | US8021690 Irridiating a part of film coating layer containing one or more colorants with light to form solid preperation coated with a continuous film coating layer; the film coating agent consists of hydroxypropylmethyl cellulose or methyl cellulose |
| 09/20/2011 | US8021689 Nanoparticles for immunotherapy |
| 09/20/2011 | US8021688 Solid dispersion is formed from at least one active component and a carrier characterized in that the carrier is a mixture of polyvinylpyrrolidone (PVP), a polyethylene glycol (PEG) which is semi-solid or solid at temperatures of 17 to 22 |
| 09/20/2011 | US8021687 Modified release compositions of milnacipran |
| 09/20/2011 | US8021686 Serum and/or intercellular degradation and clearance prevention; delivering antisense nucleic acids and/or ribozymes; high drug to lipid ratios |
| 09/20/2011 | US8021684 Haemostatic composition comprising hyaluronic acid |
| 09/20/2011 | US8021683 non-volatile silicone fluid in admixture with fumed silica, a volatile diluent and a silicone elastomer spray to reduce scar formation and prevent the growth of pathogens at the wounded target tissue site |
| 09/20/2011 | US8021680 Controlled release bioactive agent delivery device |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | US8021652 Biodegradable branched polylactide derivatives capable of forming polymeric micelles, and their preparation method and use |
| 09/20/2011 | US8021649 Continuous spray scalp therapy and dispensing systems for same |
| 09/20/2011 | US8021357 Body-insertable apparatus |
| 09/20/2011 | US8021356 Capsule medication administration system, medication administration method using capsule medication administration system, control method for capsule medication administration system |
| 09/20/2011 | CA2687491C Extended release formulation of nevirapine |
| 09/20/2011 | CA2525470C External patch containing estrogen and/or progestogen |
| 09/20/2011 | CA2507561C A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 09/20/2011 | CA2504377C Pharmaceutical preparation of recombinant factor viii lyophilized without albumin as a stabilizer |
| 09/20/2011 | CA2492874C Taste masked oral composition of telithromycin |
| 09/20/2011 | CA2484953C Microbial cellulose wound dressing for treating chronic wounds |
| 09/20/2011 | CA2476859C Water-based delivery systems |
| 09/20/2011 | CA2473209C Stimulation of the immune system with polydextrose |
| 09/20/2011 | CA2473200C Extended release compositions comprising as active compound venlafaxine hydrochloride |
| 09/20/2011 | CA2470102C Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 09/20/2011 | CA2436386C Polyacrylic film forming compositions |
| 09/20/2011 | CA2426334C Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/20/2011 | CA2425193C Oligonucleotide - facilitated coalescence |
| 09/20/2011 | CA2418135C Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 09/20/2011 | CA2395814C Glp-2 formulations comprising phosphate buffer, l-histidine and mannitol or sucrose |
| 09/20/2011 | CA2367373C Medicinal compositions |
| 09/20/2011 | CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 09/20/2011 | CA2259144C Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 09/20/2011 | CA2225796C Novel formulation for peptide release |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/17/2011 | CA2697804A1 System and process for producing multi-component biopharmaceuticals |
| 09/16/2011 | CA2730598A1 Modulating drug release rate by controlling the kinetics of the ph transition in hydrogels |
| 09/15/2011 | WO2011113065A2 Pegylated polyplexes for polynucleotide delivery |
| 09/15/2011 | WO2011112996A2 Injectable drug delivery system |
| 09/15/2011 | WO2011112922A2 Co-crystals and pharmaceutical formulations comprising the same |
| 09/15/2011 | WO2011112900A2 Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 09/15/2011 | WO2011112893A2 Compositions for ameliorating cell proliferative disorders and methods of making and using them |
| 09/15/2011 | WO2011112889A2 β-MANNOSYLCERAMIDE AND STIMULATION OF NKT CELL ANTI-TUMOR IMMUNITY |
| 09/15/2011 | WO2011112883A1 Triggered cargo release from nanoparticle stabilized liposomes |
| 09/15/2011 | WO2011112875A2 Foamable formulation |
| 09/15/2011 | WO2011112801A2 Dual function product |
| 09/15/2011 | WO2011112799A2 Structured non-aqueous gel-form carrier composition |
| 09/15/2011 | WO2011112797A2 Silky-feeling non-aqueous structured composition |
| 09/15/2011 | WO2011112793A2 Non-aqueous structured compositions |
| 09/15/2011 | WO2011112771A1 Quick dissolve nutritional powder |
| 09/15/2011 | WO2011112732A2 Methods of treating vascular inflammatory disorders |
| 09/15/2011 | WO2011112709A1 Alcohol resistant enteric pharmaceutical compositions |
| 09/15/2011 | WO2011112679A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 09/15/2011 | WO2011112364A1 Nanostructure-enhanced platelet binding and hemostatic materials and structures |
| 09/15/2011 | WO2011112229A2 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 09/15/2011 | WO2011112161A1 Extended release thiocolchicoside tablets |
| 09/15/2011 | WO2011112160A1 Extended release trimetazidine tablets |
| 09/15/2011 | WO2011112116A1 Bath drug and method for using said drug in the treatment and prophylaxis of discirculatory encephalopathy |
| 09/15/2011 | WO2011112070A2 A composition to boost and enhance immune system and method of preparing thereof |
| 09/15/2011 | WO2011111962A2 Iontophoresis patch |
| 09/15/2011 | WO2011111818A1 Sustained release type pharmaceutical composition containing mosapride or salt thereof |
| 09/15/2011 | WO2011111809A1 Ketoprofen-containing aqueous adhesive skin patch |
| 09/15/2011 | WO2011111804A1 Antiprotozoal compound originating in coelenterata |
| 09/15/2011 | WO2011111794A1 Fine-particle dispersion liquid manufacturing method and fine-particle dispersion liquid manufacturing apparatus |
| 09/15/2011 | WO2011111581A1 Therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury |
| 09/15/2011 | WO2011111481A1 Medical agent introduction sheet and kit |
| 09/15/2011 | WO2011111384A1 Transdermal composition containing therapeutic agent for parkinson's disease |
| 09/15/2011 | WO2011111084A1 Pharmaceutical composition based on glycyrrhizin and eg56 polymer for the preparation of anti-inflammatory products |
| 09/15/2011 | WO2011111068A2 Gastroretentive, extended release composition of therapeutic agent |
| 09/15/2011 | WO2011110989A1 A device for the manufacture of a dosage form with a hole and method of manufacture |
| 09/15/2011 | WO2011110939A2 Pharmaceutical compositions of substituted benzhydrylpiperazines |
| 09/15/2011 | WO2011110694A2 Micelle compositions and process for the preparation thereof |
| 09/15/2011 | WO2011110662A1 Supported biologically active compounds |
| 09/15/2011 | WO2011110478A1 Dabigatran etexilate-containing pharmaceutical composition |
| 09/15/2011 | WO2011110407A2 Micelle compositions and process for the preparation thereof |
| 09/15/2011 | WO2011110347A2 Compositions for colon lavage and methods of making and using same |
| 09/15/2011 | WO2011110344A1 Multi-particulate pharmaceutical formulation for colon absorption |
| 09/15/2011 | WO2011110225A1 Adhesive patch for therapeutic agent delivery |
| 09/15/2011 | WO2011110186A1 Cobalt/silver core shell nanoparticles application in solid tumor treatment |
| 09/15/2011 | WO2011082196A3 Rapid reconstitution for lyophilized-pharmaceutical suspensions |
| 09/15/2011 | WO2011063150A3 Oral formulation for dexlansoprazole |
| 09/15/2011 | WO2011057224A3 Zwitterionic polymer bioconjugates and related methods |
| 09/15/2011 | WO2011053789A3 Pharmaceutical composition and methods to enhance cytotoxic t-cell recognition and maintain t-cell memory against a pathogenic disease |
| 09/15/2011 | WO2011053653A3 Prevotella histicola preparations and the treatment of autoimmune conditions |
| 09/15/2011 | WO2011044545A3 Methods and compositions for targeted imaging |
| 09/15/2011 | WO2011037550A3 Dry powder combination of tiotropium |
| 09/15/2011 | WO2011031524A3 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 09/15/2011 | WO2011029892A3 Highly concentrated pharmaceutical formulations comprising anti - cd20 antibody |
| 09/15/2011 | WO2011029028A3 Targeted delivery using tissue-specific peptidomimetic ligands |